Utomilumab may enhance effectiveness of CAR-T for advanced large B-cell lymphoma

Transplantation and Cellular Therapy 2022: Study examined utomilumab combined with CAR-T therapy axicabtagene ciloleucel to increase efficacy in patients with large B-cell lymphomas.